NCT07015203

Brief Summary

The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic. The combined first trimester screening is aimed at predicting and detecting the most serious obstetric complications, such as the great obstetrical syndromes (preeclampsia, fetal growth restriction, preterm labor and intrauterine fetal demise "IUFD") and structural congenital defects (morphological and chromosomal). The primary objective of the project is to create a unified methodology for performing and evaluating the combined first trimester screening in connection with the National Health Information System (hereinafter referred to as "NHIS"), which will enable recording, providing analysis and linking recorded clinical parameters with data in the NHIS. The pilot project will also provide data for modeling appropriate mechanisms for reimbursement from public health insurance.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
11mo left

Started Jun 2025

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress53%
Jun 2025Apr 2027

First Submitted

Initial submission to the registry

June 3, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 11, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

June 15, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

1.4 years

First QC Date

June 3, 2025

Last Update Submit

April 16, 2026

Conditions

Keywords

preeclampsiapredictionpreventionmaternal risk factorsMean Arterial PressureUterine artery Pulsatility IndexPlacental Growth Factoracetylsalicylic acidCzech Republic

Outcome Measures

Primary Outcomes (1)

  • Proportion of women with identified increased risk of Preeclampsia, Fetal Growth Restriction or Fetal Chromosomal Aneuploidies (trisomies of chromosomes 21, 18 and 13)

    From June 2025 to October 2026

Study Arms (1)

A woman over 18 years old in the first trimester of pregnancy (11th-13th gestational week)

A participant in the project must have signed the Consent to Participate in the Project and the Consent to the Processing of Personal Data.

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women matching all inclusion criteria \& GDPR.

You may qualify if:

  • A woman over 18 years old in the first trimester of pregnancy (11th-13th gestational week)
  • Signed the Consent to Participate in the Project and GDPR.

You may not qualify if:

  • Unsigned the Consent to Participate in the Project and the Consent to the Processing of Personal Data.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Regional Health Corpotarion - Most Hospital

Most, Czechia, Czechia

RECRUITING

University Hospital Olomouc

Olomouc, Czechia, Czechia

RECRUITING

Institute for the Care of Mother and Child

Prague, Czechia, Czechia

RECRUITING

MeSH Terms

Conditions

Pre-EclampsiaFetal Growth RetardationCongenital AbnormalitiesObstetric Labor, PrematureStillbirthGenetic Diseases, Inborn

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesFetal DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGrowth DisordersPathologic ProcessesPathological Conditions, Signs and SymptomsObstetric Labor ComplicationsFetal DeathDeath

Study Officials

  • Marek Ľubušký, prof.

    THE FETAL MEDICINE CENTRE, Department of Obstetrics and Gynecology, Palacky University Olomouc, Faculty of Medicine and Dentistry, University Hospital Olomouc

    STUDY DIRECTOR

Central Study Contacts

Petra Brlica Heideová, Msc.

CONTACT

Lucie Mandelová, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2025

First Posted

June 11, 2025

Study Start

June 15, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

April 30, 2027

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations